Articles On BOD Australia (ASX:BDA)

Telix Pharmaceuticals will benefit from ongoing favourable US pay arrangements for high-value radiopharmaceutical diagnostics Optiscan teams with Monash University to develop a next-gen endomicroscope – and AI is involved BOD Australia inv...

Neurotech says due to often negative publicity around cannabis companies it tends not to promote itself as one Neurotech taking drug development approach to lead product NTI164, meaning it will be registered as a prescription-only BOD Aust...

Several ASX companies are undergoing rigorous clinical trials to gain regulatory approval for their cannabinoid products BOD Australia could have the first Schedule 3 CBD product in Australia following positive results from its Phase 2B Ca...

Penington Institute says pot-related law enforcement costs us $1.7 billion a year   Local cannabis is missing out on international and domestic market opportunities Aussie medicinal cannabis revenue was around $230 million in 2021   Decri...

ASX 200 ends 0.7% higher. Small cap index rises 0.2% Codrus latest REE newcomer to go tik-tik boom! All of the top 15 small cap gainers today are in the resources space. The benchmark has risen 0.7% and the ASX Emerging Companies (XEC) in...

Two more US states join the 19 that already allow legal recreational cannabis use ECS Botanics’ Victorian medical cannabis facility is safe from flooding in the state, so far Cann looks to commercialise its Satipharm CBD capsules for over-...

Germany looks to legalise recreational cannabis and US and Canadian companies are paying attention  Neurotech reports success with its cannabis-based drug for paediatric autism symptoms  ECS Botanics has sold its Tasmanian business and a...

Cambridge says cannabis smokers are not actually lazy, that’s a myth USyd wants to test home-grown cannabis in the ACT Incannex joins the big leagues S&P/ASX300 index   It turns out that the lazy stoner stereotype is actually a myth,...

Researchers say data shows transition from illicit to legal use of cannabis Medicinal users are at 37%, compared to 2.5% in 2018 Regulations, quality control and costs still barriers for legal week users   New research from the University...

Invex receives IND approval from the US FDA Antisense reveals positive study in Long Covid-19 Bod gets US certification Invex Therapeutics (ASX:IXC) jumped 20% this morning after receiving a Investigational New Drug Application (IND) appr...

Ice-T is opening a cannabis dispensary in New Jersey this year Snoop Dogg’s venture capital firm led a seed funding round for TSUMo Snacks Incannex ramps up development and manufacturing of IHL-216A drug New Jersey has given Ice-T the gre...

Mysterious pink glow over Mildura Thailand businesses go nuts for CBD desserts and bubble tea ECS nabs $2m commercial loan facility to invest in new capacity ICYMI a mysterious pink glow above Mildura sent residents into a bit of a frenzy...

ECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensaries in the US Zelira Therapeutics nabs regulatory approval in Germany for insomnia medication Ever fancied your own cannabis farm? Well, t...

The ASX 200 closed higher and small caps lower as investors sought for bargains amid the Wednesday resources wreck. Overnight in New York, the Dow Jones closed 0.2% ahead as the US jobs market continued to display especial vigour. The S&amp...

Retail and independent cannabis lounges could be opening soon in Vegas Cann Group gets good manufacturing practice (GMP) licence for its Mildura facility Bod plans to launch a low dose CBD schedule 3 product into the Australian market  ...

A Thai university says adding cannabis to chicken feed has positive results on meat and egg quality Aussie cannabis campaigner now a Member of the Order of Australia MGC Pharma’s CBD treatment proves effective against brain tumors   Chian...

Boston Beer Co launches cannabis iced tea in Canada University of Sydney says using CBD and driving is no worries Emyria reports positive Phase 1 study results for ultra-pure CBD capsule The Boston Beer Co is launching a line of cannabis-...

Actor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wellness retreat in Byron Bay Incannex wants to buy out APIRx   It’s not surprising that Woody Harrelson loves weed – the actor was actually...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Actor and cannabis farmer Jim Belushi is headlining the Grow Up Conference and Expo next month Franchise Global Health has established the first legal seedbank in Denmark Botanix nabs FDA Qualified Infection Disease Product designation for...

US Seed Connect launched Cannabis Crypto Seed Headz NFT Washington launches week-long cannabis tax holiday Medlab clinical makes moves in the Northern Hemisphere with manufacturing deal Wednesday was 4/20 day – while it’s more of an unoff...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ACIC says weed consumption increased in cities and regions ROO receives USA design patent approval for its Heat Exchange Probe EMD has launched its second ultra-pure CBD capsule, the EMD-RX7   The latest Australian Criminal Intelligen...

Hemp farmers in New York have been given the go ahead to plant cannabis for the 2022 season. The legislation allows conditionally licensed cannabis farmers to grow weed, but they must meet certain requirements, including safe, sustainable a...

In December France banned the sale of hemp flower and leaf loaded with CBD, but the Conseil d’Etat provisionally overruled the decision on Wednesday – pending further examination of the order. Basically, the French court said that flowers...

The Australian medicinal cannabis market has seen strong growth in 2021, with revenue from product sales estimated at $230 million. And medical cannabis prescriptions are at an all-time high. The TGA said 13,666 Australian patients were app...

Uber is expanding its horizons, with plans to allow users to order cannabis on its Uber Eats app. Next week the app will list cannabis retailer Tokyo Smoke on its marketplace and customers will be able to place orders on the app – but they...

Instead of a chocolate advent calendar this year, Californians can get their hands on a cannabis calendar with edibles, prerolls, grams of flower and four days of cannabis accessories. “We’ve seen the success of unique advent calendars in o...

Actor Jim Belushi has partnered with – you guessed it – Dan Aykroyd on a tour through Oklahoma’s cannabis industry ahead of a Blues Brothers performance. “We believe that cannabis is one of the great, great medicines that can lead to a path...

On October 6, California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sales of hemp-derived CBD products in the state. Hemp has been legalised at the US federal level since 2018, but state agencies have been s...

Retail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired for testing positive for marijuana to reapply for jobs. The company has now excluded marijuana from its comprehensive pre-employment drug scr...

The S&P/ASX 200 index (ASX: XJO) has spent the day in the green and is currently 0.5% higher at 7,309.7 points. Healthcare shares are amongst the strongest performers leading the broad index’s recovery today, with the S&P/ASX 200...

Massachusetts based cannabis operator MariMed has just announced a joint collaboration with the legendary Boston ice cream brand Emack & Bolio’s® to create a line-up of cannabis-infused vegan and dairy ice cream. The ice cream will cont...

This week Technicorum Holdings announced an upcoming token sale and launch of The CanCoin – a cannabis token designed to solve market friction and monetisation in the European cannabis market and to help build blockchain-based solutions for...

Summary The ASX 200 ended 43 points or 0.59% higher at 7308.60, led by gains in energy, telecom, and banks Barring tech and consumer staples, all sectors ended in green. Edutech firm IDP Education was the top gainer, while intellectua...

Summary The ASX 200 was trading higher by 21.90 points or 0.30% at 7,287.50 by Friday afternoon. Barring tech, all sectors were trading in green, while energy was the top gainer. Gaming start-up BlueBet Holding made strong debut on th...

The Bod Australia Ltd (ASX: BDA) share price is a strong performer today following the release of a sales update. At the time of writing, shares in the CBD and hemp healthcare products company are up 3% to 35 cents. What’s driving the Bod...

Fiscal 2021 sales figures released by medicinal cannabis, CBD and hemp healthcare products company, Bod Australia Limited (ASX:BDA) could well be the catalyst for a substantial share price rerating given that they represent record medicinal...

Summary The ASX 200 traded lower by 35.20 points or 0.48% at 7,351, weighed down by sharp selling in materials and energy stocks. The market sentiment was dampened by report that the US Fed may announce sooner-than-expected rise in int...

Following the launch of two new CBD-based products under the CBII brand, Bod Australia Limited (ASX:BDA) today announced that it has broadened its sales footprint in the United Kingdom via two new online retailers. Bod’s entire range of CBI...

Summary Oncology firm Telix Pharmaceuticals has entered into an exclusive commercial distribution agreement to distribute its product in the German market. Proteomics has secured a significant contract for pharmacokinetic testing, whil...

Summary PPK Group’s 48% owned subsidiary, Li-S Energy Limited has developed a revolutionary lithium sulphur battery. Eastern Iron has completed its entitlement offer, raising up to approximately AU$1,072,370. BOD Australia has announc...

Medicinal Cannabis, CBD and hemp healthcare products company, Bod Australia Limited (ASX:BDA) has provided a promising update on its new medicinal cannabis product launch, as well as highlighting recent MediCabilisTM prescription growth in...

LBT Innovations (ASX:LBT) shares rose this morning after it sold its first two pathology sample analysers in the UK. LBT’s APAS Independence (Automated Plate Assessment System) sorts medical samples and uses AI and machine learning to deter...

Summary Bod Australia has reported highest ever monthly sales of medicinal cannabis products in April. The sales accounted for around 27% of the total special access scheme category B prescriptions filled across Australia in April 2021...

The ASX had a solid start to the week, gaining over 1 per cent and hitting a record high. The ASX 200 closed 1.3 per cent up at 7,172.8 which is a record closing high although not quite an all-time intra day high. The #ASX 200 rose by 92pt...

Summary Oncology player Telix Pharmaceuticals has commenced Phase 3 clinical trial of its prostate cancer therapy candidate. Polymer implants manufacturer Osteopore Limited has obtained CE certification for a significantly broader rang...

Bod Australia (ASX:BDA) today announced its highest ever monthly sales for its medicinal cannabis prescription products. During April, BDA filled a total of 1,789 MediCabilisTM prescriptions in Australia, an 11% increase on the previous mon...

The Bod Australia Ltd (ASX: BDA) share price is smoking the ASX today following the release of a positive sales update. At the time of writing, shares in the cannabis healthcare company are trading 21.6% higher at 45 cents. In comparison,...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...